Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms LP 102, LP-102 |
Target |
Mechanism CD3 modulators(T cell surface glycoprotein CD3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Preclinical | CN | - | |
Diffuse Large B-Cell Lymphoma | Preclinical | CN | - |